Dialogue Health Technologies Inc.
DLHTF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $87 | $68 | $36 | $10 |
| % Growth | 28% | 90.1% | 254.9% | – |
| Cost of Goods Sold | $44 | $39 | $21 | $5 |
| Gross Profit | $43 | $29 | $14 | $5 |
| % Margin | 49.7% | 42.3% | 40.2% | 54.4% |
| R&D Expenses | $11 | $10 | $5 | $3 |
| G&A Expenses | $46 | $34 | $20 | $9 |
| SG&A Expenses | $59 | $46 | $30 | $14 |
| Sales & Mktg Exp. | $13 | $12 | $9 | $5 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $69 | $55 | $35 | $17 |
| Operating Income | -$26 | -$27 | -$20 | -$12 |
| % Margin | -29.8% | -39.1% | -56.2% | -116.5% |
| Other Income/Exp. Net | -$0 | -$225 | -$0 | -$0 |
| Pre-Tax Income | -$26 | -$252 | -$20 | -$12 |
| Tax Expense | -$0 | -$0 | -$0 | $0 |
| Net Income | -$26 | -$251 | -$20 | -$12 |
| % Margin | -29.8% | -369.4% | -56.5% | -119.4% |
| EPS | -0.39 | -4.48 | -0.31 | -0.19 |
| % Growth | 91.3% | -1,345.2% | -63.2% | – |
| EPS Diluted | -0.39 | -4.48 | -0.31 | -0.19 |
| Weighted Avg Shares Out | 66 | 56 | 65 | 65 |
| Weighted Avg Shares Out Dil | 66 | 56 | 65 | 65 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $4 | $3 | $2 | $1 |
| EBITDA | -$21 | -$249 | -$17 | -$11 |
| % Margin | -24.5% | -366.2% | -48.4% | -108.3% |